Screener
Eligibility screening
Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors
8 US sites in GA, MI, NJ, NY +2
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors
8 US sites in GA, MI, NJ, NY +2
Before we begin
Your answer affects how the questions are phrased.